{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:47Z","timestamp":1761807887172},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jbspin.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T05:16:17Z","timestamp":1393650977000},"page":"308-312","source":"Crossref","is-referenced-by-count":9,"title":["Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis?"],"prefix":"10.1016","volume":"81","author":[{"given":"Dewi","family":"Guellec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtane","family":"Nocturne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Tatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cantagrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.01.003_bib0005","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.20985","article-title":"Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","article-title":"Efficacy of celecoxib, a cyclo-oxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional non-steroidal anti-inflammatory drug","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bmj.4.5943.496","article-title":"Double-bind cross-over trial of flurbiprofen and phenylbutazone in ankylosing spondylitis","volume":"4","author":"Calin","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"Assessment of SpondyloArthritis international Society. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among non-steroidal anti-inflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Mass\u00f3 Gonz\u00e1lez","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0030","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2125.1997.00631.x","article-title":"Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study","volume":"44","author":"Henry","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0040","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Non-steroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0050","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"71","author":"Poddubnyy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0055","article-title":"Continuance of non-steroidal anti-inflammatory drugs may reduce radiographic progression in ankylosing spondylitis patients on biological therapy","author":"Haroon","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0060","first-page":"60","article-title":"Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone","volume":"5","author":"Boersma","year":"1976","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0065","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter","volume":"50","author":"Wanders","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0070","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2006.052308","article-title":"A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip","volume":"66","author":"Luyten","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0080","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3899\/jrheum.110636","article-title":"Treatment of osteoarthritis with continuous versus intermittent celecoxib","volume":"38","author":"Strand","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0085","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclo-oxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8","article-title":"Expression of cyclo-oxygenase 1 and cyclo-oxygenase 2 in human synovial tissue: differential elevation of cyclo-oxygenase 2 in inflammatory joint diseases","volume":"41","author":"Siegle","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jbspin.2013.06.003","article-title":"Do non-steroidal anti-inflammatory drugs have disease-modifying effects in spondyloarthritis?","volume":"80","author":"Wendling","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.01.003_bib0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jbspin.2012.12.002","article-title":"Vascular effects of non-steroidal anti-inflammatory drugs","volume":"80","author":"Soubrier","year":"2013","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T08:51:58Z","timestamp":1538815918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1297319X14000050"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.01.003","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}